
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China
SHANGHAI and HONG KONG, March 3, 2026 /PRNewswire/ -- Hua Medicine (the Company, Hong Kong Stock Exchange Stock Code: 2552.HK) announced today that its global first-in-class glucokinase activator (GK… [+12138 chars]









